Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2022 - Issue 4

Nephropathy in Adolescents with Type 1 Diabetes Mellitus: Systematic Review Download PDF


, , , , , , , , ,
Abstract

Diabetic nephropathy (DN) is an emerging public health and clinical issue linked to heart failure, ESRD, and other negative effects, including renal replacement therapy. A systematic search of five major databases, including PubMed, Web of Science, Science Direct, EBSCO, and Cochrane library, was conducted to comprise eligible literature for research. This systematic review studies the risk factors associated with the development of DN and albuminuria in adolescents suffering from T1DM. A total of 13 study articles with 1489 patients were included in this review. Hypertension in association with albuminuria was found in six studies, high mean HbA1c in association with DN was demonstrated in all the included studies, and dyslipidemia/ high total cholesterol level was reported in three studies. Hypertension, high HbA1C (poor glycemic control), dyslipidemia, high cholesterol levels, and high BMI indicating overweight or obesity are risk factors for the incidence of microalbuminuria and DN in adolescents with T1DM.

Cite this article
Vancouver
AlEdeilah RD, AlSulailm AS, AlAnazi SM, AlAnazi MF, AlEnazi NFN, Alanazi RRMSAASA, et al. Nephropathy in Adolescents with Type 1 Diabetes Mellitus: Systematic Review. Pharmacophore. 2022;13(4):135-41. https://doi.org/10.51847/eC6QibkaX4
APA
AlEdeilah, R. D., AlSulailm, A. S., AlAnazi, S. M., AlAnazi, M. F., AlEnazi, N. F. N., Alanazi, R. R. M. S. A. A. S. A., ALzahrani, K. A., Al Bogami, N. M., Moafa, R. H., & AlMutairi, M. H. (2022). Nephropathy in Adolescents with Type 1 Diabetes Mellitus: Systematic Review. Pharmacophore, 13(4), 135-141. https://doi.org/10.51847/eC6QibkaX4

QR code:

Short Link:
Views: 113

Downloads: 26
Quick Access

Pharmacophore
ISSN: 2229-5402

Pharmacophore
© 2024 All rights reserved
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.